Bill & Melinda Gates Foundation Vir Biotechnology, Inc. (VIR) insider trading activity

Bill & Melinda Gates Foundation is of Vir Biotechnology, Inc.. Currently has a direct ownership of 2.78 Million shares of VIR, which is worth approximately $20.6 Million. The most recent transaction as insider was on Oct 16, 2019, when has been sold 2,777,777 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.78M

0% 3M change

0% 12M change

Total Value Held $20.6 Million

Bill & Melinda Gates Foundation Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 16 2019	BUY Conversion of derivative security	-	2,777,777 Added 50.0%	2,777,777 Common Stock

Also insider at

XFOR

X4 Pharmaceuticals, Inc Healthcare

LQDA

Liquidia Technologies Inc

BCEL

Atreca, Inc. Healthcare

B&M